Medicine & Life Sciences
Mucin-2
100%
N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide
80%
Pseudomyxoma Peritonei
73%
Mitogen-Activated Protein Kinases
57%
Growth
29%
Neoplasms
18%
Heterografts
17%
Activating Transcription Factor 1
16%
Proteins
14%
Mitogen-Activated Protein Kinase 1
10%
Peritoneal Cavity
10%
Mitogen-Activated Protein Kinase Kinases
10%
Extracellular Signal-Regulated MAP Kinases
10%
Mucins
10%
Gels
7%
Phosphotransferases
7%
Down-Regulation
6%
Phosphorylation
6%
Morbidity
5%
Messenger RNA
5%
Survival
5%
Mortality
4%
In Vitro Techniques
4%
Therapeutics
3%
Chemical Compounds
Protein
24%
EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor
11%
Messenger RNA
9%
Intraperitoneal
9%
Phosphotransferase Inhibitor
9%